Navigation Links
Mr. Robert Andrews Joins Asymchem Life Science (Tianjin) Co. Ltd. as Vice President of Quality Assurance
Date:3/25/2011

MORRISVILLE, N.C., March 25, 2011 /PRNewswire/ -- Asymchem Life Science (Tianjin) Co. Ltd, a leading research-based contract manufacturer of advanced intermediates and API's to the pharmaceutical industry, with sites in the U.S. and China, is pleased to announce the recent addition of Mr. Robert Andrews as Vice President of Quality Assurance as of March 1, 2011.

Mr. Andrews brings to the table over 18 years' experience in the pharmaceutical industry (early and late stage), in quality assurance and quality control. Prior to Asymchem, he worked for solid dosage softgel and softlet manufacturer Banner Pharmacaps, Inc. as a part of their Global Technical Support Management at a total of five plants worldwide. Additionally, Mr. Andrews has worked in many medical and pharmaceutical enterprises in positions such as Senior Consultant of Quality Management at TSI Health Sciences, Inc and Division Quality Manager at Pridecraft Enterprises.

In his previous role, while focusing on quality management and supervision, he handled twenty US FDA, NCDA and DEA Inspections. He has offered technical support and quality management to six API plants and seven solid dosage facilities located throughout China, establishing an experienced foundation for his work coming into Asymchem.

As Vice President of Quality Assurance, Mr. Andrews will have overall responsibility for Asymchem's quality assurance program and management, improving upon Asymchem's cGMP QA management system to align and communicate with customers closely on quality issues. In addition, Mr. Andrews will be responsible for organizing and implementing training with regards to GMP and quality management throughout Asymchem.

"I am very pleased to have Mr. Andrews on board to help strengthen and expand Asymchem's established Quality Assurance program," states Dr Hao Hong, CEO of Asymchem. "With his broad experience in the regulatory and pharmaceutical industry, and proven track record of quality management in API manufacturing, I am confident that our QA program will stay on course for continual improvement."

Asymchem is a leading research-based contract manufacturer specializing in the development and compliant manufacturing (Contract Research and Manufacturing Services) of API's and Drug Products serving the pharmaceutical industry. With a 15 year track record, Asymchem is committed to the highest level of quality and excellence in the integrated CMC services arena. For further information, please visit the Asymchem website at www.asymchem.com.


'/>"/>
SOURCE Asymchem Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SGS Robert Burek to Speak at Medical Device Standards Seminar March 24
2. Polaris Group Appoints Robert E. Hoffman as Chief Financial Officer
3. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
4. Uroplasty Announces Addition of Robert Kill to its Board of Directors
5. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
6. CNBC, Discovery Channel and National Geographic to Cover Dr. Robert Melamede and Richard Cowan of Cannabis Science Whom are Speaking at The Marijuana Conference in New York City on Oct. 25 & 26
7. CVS Caremark Appoints Jonathan C. Roberts as PBM Chief Operating Officer
8. Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Conferences
9. Media Statement: Robert Moussa, President and CEO, Dilon Diagnostics
10. North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group
11. Watson Promotes Robert Stewart to Executive Vice President, Global Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt University ... first patients in Nashville , Tennesse ... Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. ... to provide long-term reflux control by restoring normal function ... nearly 65 million people in the United ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
Breaking Medicine Technology:
(Date:4/22/2017)... ... April 22, 2017 , ... Brian Emmer brings more than ... and Business Development at OAKWORKS, Inc. Mr. Emmer is responsible for the ... planning for the company. Recognized industry-wide as a healthcare innovator, Emmer has ...
(Date:4/21/2017)... ... ... at Palm Beach Face is proud to announce that their practice founder, Michael Schwartz ... place on April 23rd, the London Marathon has a long tradition of raising funds for ... EMPOWER, raising money for the international charity, Smile Train. , Started in 1981 ...
(Date:4/21/2017)... ... 21, 2017 , ... Brady (NYSE:BRC), a global leader in industrial ... B-7569 vinyl label materials received certification for the BS5609 British Marine Standard. ... intact and legible, for use on chemical drums shipped by sea. , ...
(Date:4/21/2017)... , ... April 21, 2017 , ... The Patient Advocacy ... Health System, with the 2017 Ruth Ravich Patient Advocacy Award in recognition ... advocates. DeVaro was honored with the award at The Beryl Institute’s annual Patient ...
(Date:4/21/2017)... ... April 21, 2017 , ... The American Medical Student Association ... and Recovery Education, from April 24 to April 28, 2017, dedicated to increasing ... , The mission of AWARE is to instill a compassionate, total health approach ...
Breaking Medicine News(10 mins):